TGFB1 and metabolic dysfunction-associated steatotic liver disease: Selenium shows significant inhibitory effects on metalloproteinases, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), transforming growth factor-beta1, and other cytokines and growth factors involved in NAFLD development, helping to reduce hepatic inflammation [27, 28].